MWM
EW icon

Maridea Wealth Management’s Edwards Lifesciences EW Stock Holding History

Maridea Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
20,986
+4,564
+28% +$376K 0.24% 103
2025
Q4 		$1.4M Buy
16,422
+4,352
+36% +$357K 0.21% 122
2025
Q3 		$909K Buy
+12,070
New +$943K 0.14% 150

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Maridea Wealth Management's EW Position: Q1 2026 in Review

Maridea Wealth Management increased its Edwards Lifesciences (EW) stake by 28% in Q1 2026, buying an estimated $376K and bringing the position to 20,986 shares worth $1.68M. The position accounts for 0.24% of the portfolio, ranked #103.

Maridea Wealth Management first reported a position in EW in Q3 2025 and has held it in 3 quarters since. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Maridea Wealth Management held 20,986 shares of Edwards Lifesciences worth $1.68M as of Q1 2026.
  • Maridea Wealth Management bought 4,564 Edwards Lifesciences shares in Q1 2026, an estimated $376K.
  • Edwards Lifesciences made up 0.24% of Maridea Wealth Management's portfolio in Q1 2026, its #103 holding.
  • Maridea Wealth Management first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 3 quarters since.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Maridea Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.